Breaking News

Thermo Fisher Scientific Expands GlobalAccess Sequencing Program

Extends program benefits to oncology labs and fast-tracks access to comprehensive molecular profiling on the Genexus System.

By: Contract Pharma

Contract Pharma Staff

Thermo Fisher Scientific has expanded its GlobalAccess Sequencing Program to include laboratories working in oncology. Originally introduced to accelerate multi-institutional-led studies focused on SARS-CoV-2, the expanded program now provides support to labs facing significant constraints as a result of the global pandemic by offering faster access to comprehensive, single-day molecular profiling of tumor tissue on Thermo Fisher’s Ion Torrent Genexus System. Under the GlobalAccess Seq...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters